CHRISTIAN HENRY BERNARDO: Open Payments
NPI 1982197554 · POMONA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$824 in 32 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $214 · 2025 $824
Food & beverage: $824
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 8 | $248 |
| ABBVIE INC. | 5 | $125 |
| Alkermes, Inc. | 4 | $111 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| Janssen Pharmaceuticals, Inc | 3 | $82 |
| Teva Pharmaceuticals USA, Inc. | 4 | $81 |
| E.R. Squibb & Sons, L.L.C. | 3 | $78 |
| Luye Pharma (USA) Ltd. | 1 | $14 |
Products named: INGREZZA, VRAYLAR, ARISTADA, ABILIFY ASIMTUFII, INVEGA SUSTENNA, UZEDY, COBENFY, VIVITROL.
Industry payments across CA — which companies pay providers there.
